Galenika Acquires Lifemedic and Further Expands Its Portfolio

10/20/2023   •   Customer news
Galenika Acquires Lifemedic and Further Expands Its Portfolio
Pharmaceutical company Galenika, one of the largest producers of pharmaceutical products in Serbia and the region, is expanding its business through the acquisition of Lifemedic d.o.o. from Belgrade. With this transaction, Galenika becomes the owner of the 100% Serbian-Slovenian company Lifemedic and takes over the exclusive distribution of the product program of the renowned Italian pharmaceutical company Pharmalife Research, for the markets of Serbia, Bosnia and Herzegovina, North Macedonia and Montenegro. 

The transaction will be completed after the approval process by the antimonopoly commissions in the markets of Serbia, North Macedonia and Montenegro, and is expected at the end of fourth quarter of 2023, after which the process of integration will begin. 

Galenika company is strategically committed to constant expansion of its product portfolio for the benefit of consumers. Brand recognition, quality, reliability and trust in Galenika's products is what makes the company successful for decades. With this acquisition, the company successfully continues to expand its product portfolio. 

"Since becoming a part of the Brazilian NC Group, Galenika has achieved significant business growth and international expansion. The acquisition of the Lifemedic company and the start of cooperation with the Italian manufacturer Pharmalife Research represents another step in the internationalization of Galenika's business and confirms our full commitment to investments and innovations in accordance with the modern needs of consumers. Pharmalife Research has over 400 products in its portfolio and exports to 60 countries around the world. We are happy to have found a global partner who shares our values of commitment to product quality and health,'' said Ricardo Vian Marques, CEO of Galenika. 

Lifemedic is a Serbian-Slovenian company with years of experience in distribution of dietary supplements and cosmetic products manufactured by a prominent biopharmaceutical company - Pharmalife Research from Italy, of which it is the exclusive importer and distributor for markets in the region. The company has a stable double digit growth partnering with over 5,000 pharmacies and retail chains in the whole region. Pharmalife Research has been a reliable pharmaceutical partner in the field of pediatrics, dietary supplements, dermocosmetics and phytotherapy both in Italy and on international markets.